From The Director
| Welcome to the latest issue of the Myeloma magazine as we celebrate 35 years of outstanding patient care and leading-edge research.
The Myeloma Center is a vital component of the exceptional treatment provided at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS). Since my arrival in 2019, I have witnessed first-hand the remarkable dedication of the Myeloma Center faculty and staff under the leadership of Frits van Rhee, M.D., Ph.D.
UAMS Winthrop P. Rockefeller Cancer Institute director Michael Birrer, M.D., Ph.D.
Since the creation of the UAMS myeloma program in 1989, the management of this complex disease has progressed from standard chemotherapy to use of immunotherapies, which are easier to administer and less stressful on the patient. Many of these remedies are now available sooner after the initial myeloma diagnosis, which increases the chances of favorable results for the patient.
Translational research is a major factor in the march towards a cure for multiple myeloma. Fenghuang (Frank) Zhan, M.D., Ph.D., directs a superior program that is identifying new approaches in treating myeloma. The magazine details several sources of funding awarded to our research team, which allows us to continue on this path.
While we celebrate our past successes, we are looking towards the future. Novel therapies and advanced research are positive steps towards curing what was once thought to be an uncurable disease. This edition also contains inspirational patient stories as well as features on our superior health care professionals. Dr. van Rhee, the world’s expert on Castleman disease, discusses UAMS’ role in the treatment and understanding of this rare disease.
The UAMS Myeloma Center is the leader in myeloma care. We appreciate all who have put their trust in our team, and we will continue to do our best to deliver the care you need and deserve.
Michael Birrer, M.D., Ph.D.
Vice Chancellor, University of Arkansas for Medical Sciences
Director, Winthrop P. Rockefeller Cancer Institute
Kent Westbrook, M.D., Director’s Chair, Winthrop P. Rockefeller Cancer Institute